Innovation in Action
Clinical Trials
Baxter’s clinical trials and early-stage programs have the potential to impact the treatment and delivery of care for chronic diseases like Alzheimer's disease, hemophilia, end-stage renal disease, immune deficiencies, as well as public health threats like pandemic and seasonal influenza.
- National Institutes of Health | Clinical Trials (http://www.clinicaltrials.gov/)
